Overview
Jeffrey Pyne is an Ophthalmologist in Panama City, Florida. Dr. Pyne is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Retinal Artery Occlusion, Retinal Vein Occlusion, Glaucoma, and Age-Related Macular Degeneration (ARMD). Dr. Pyne is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Emerald Coast Eye Institute LLC
Todd Robinson is an Ophthalmologist in Fort Walton Beach, Florida. Dr. Robinson is rated as a Distinguished provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Cataract, Glaucoma, Ocular Hypertension (OHT), and Interstitial Keratitis. Dr. Robinson is currently accepting new patients.
Eye Partners PC
Marnix Heersink is an Ophthalmologist in Panama City, Florida. Dr. Heersink is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Cataract, Blepharitis, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration. Dr. Heersink is currently accepting new patients.
Eye Partners PC
John Bell is an Ophthalmologist and an Addiction Medicine provider in Panama City, Florida. Dr. Bell is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Cataract, Glaucoma, Opioid Use Disorder, and Amaurosis Fugax. Dr. Bell is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Pyne isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- Diabetic RetinopathyDr. Pyne isDistinguished. Learn about Diabetic Retinopathy.
- GlaucomaDr. Pyne isDistinguished. Learn about Glaucoma.
- Kallikrein HypertensionDr. Pyne isDistinguished. Learn about Kallikrein Hypertension.
- Late-Onset Retinal DegenerationDr. Pyne isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Retinal Artery OcclusionDr. Pyne isDistinguished. Learn about Retinal Artery Occlusion.
- Advanced
- CataractDr. Pyne isAdvanced. Learn about Cataract.
- Dry Eye SyndromeDr. Pyne isAdvanced. Learn about Dry Eye Syndrome.
- EntropionDr. Pyne isAdvanced. Learn about Entropion.
- Geographic AtrophyDr. Pyne isAdvanced. Learn about Geographic Atrophy.
- Interstitial KeratitisDr. Pyne isAdvanced. Learn about Interstitial Keratitis.
- NeuroretinitisDr. Pyne isAdvanced. Learn about Neuroretinitis.
- Experienced
- Allergic ConjunctivitisDr. Pyne isExperienced. Learn about Allergic Conjunctivitis.
- AmblyopiaDr. Pyne isExperienced. Learn about Amblyopia.
- AstigmatismDr. Pyne isExperienced. Learn about Astigmatism.
- Bietti Crystalline Dystrophy (BCD)Dr. Pyne isExperienced. Learn about Bietti Crystalline Dystrophy (BCD).
- BlepharitisDr. Pyne isExperienced. Learn about Blepharitis.
- Central Serous ChorioretinopathyDr. Pyne isExperienced. Learn about Central Serous Chorioretinopathy.